Ashish Bajel

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity

Vikram Mathews, Biju George, Kavitha M. Lakshmi et al. · Blood · 2005 · 342 citations · Full text

Medicine, Hematology, Oncology +12

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Lori Muffly, Marcelo C. Pasquini, Michael J. Martens et al. · Blood · 2017 · 296 citations · Full text

Medicine, Geriatric Medicine, Hematology +14

Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Vinod Pullarkat, Norman J. Lacayo, Elias Jabbour et al. · Cancer Discovery · 2021 · 288 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

C. Orla Morrissey, Sharon C.‐A. Chen, Tania C. Sorrell et al. · The Lancet Infectious Diseases · 2013 · 221 citations

Life Sciences, Infectious Diseases, Microbiology +17

Menin Inhibition With Revumenib for <i>KMT2A</i> -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

Ghayas C. Issa, Ibrahim Aldoss, Michael J. Thirman et al. · Journal of Clinical Oncology · 2024 · 184 citations · Full text

Medicine, Oncology, Pharmacology +12